US Bancorp DE raised its holdings in Steris PLC (NYSE:STE) by 288.8% during the fourth quarter, HoldingsChannel.com reports. The firm owned 33,966 shares of the medical equipment provider’s stock after buying an additional 25,229 shares during the period. US Bancorp DE’s holdings in Steris were worth $2,971,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Comerica Bank increased its stake in Steris by 0.9% in the fourth quarter. Comerica Bank now owns 68,219 shares of the medical equipment provider’s stock valued at $6,255,000 after purchasing an additional 628 shares during the period. CIBC World Markets Inc. acquired a new position in Steris in the fourth quarter valued at $392,000. Parametrica Management Ltd acquired a new position in Steris in the fourth quarter valued at $340,000. Dividend Assets Capital LLC increased its stake in Steris by 6.1% in the fourth quarter. Dividend Assets Capital LLC now owns 239,110 shares of the medical equipment provider’s stock valued at $20,914,000 after purchasing an additional 13,745 shares during the period. Finally, Dean Capital Investments Management LLC acquired a new position in Steris in the fourth quarter valued at $335,000. Institutional investors own 89.47% of the company’s stock.
In other news, VP Sudhir K. Pahwa sold 2,000 shares of the business’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $92.09, for a total transaction of $184,180.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Karen L. Burton sold 1,500 shares of the business’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $85.59, for a total transaction of $128,385.00. The disclosure for this sale can be found here. Insiders own 2.55% of the company’s stock.
Steris (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.05. Steris had a net margin of 9.42% and a return on equity of 11.57%. The business had revenue of $661.90 million for the quarter, compared to analyst estimates of $663.17 million. During the same period in the previous year, the business posted $0.98 earnings per share. The business’s revenue was up 2.3% compared to the same quarter last year. research analysts predict that Steris PLC will post 4.13 EPS for the current year.
A number of research firms have commented on STE. KeyCorp restated a “buy” rating and issued a $103.00 price objective on shares of Steris in a research note on Thursday, February 8th. Northcoast Research set a $102.00 price objective on shares of Steris and gave the company a “buy” rating in a research note on Thursday, February 8th. Zacks Investment Research lowered shares of Steris from a “buy” rating to a “hold” rating in a research note on Wednesday, January 24th. Raymond James Financial restated a “market perform” rating and issued a $100.00 price objective on shares of Steris in a research note on Wednesday, January 3rd. Finally, TD Securities lifted their price objective on shares of Steris from C$14.00 to C$16.00 and gave the company a “buy” rating in a research note on Thursday, November 9th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Steris presently has a consensus rating of “Buy” and an average price target of $84.80.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Markets Daily and is owned by of Markets Daily. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.themarketsdaily.com/2018/02/15/us-bancorp-de-acquires-25229-shares-of-steris-plc-ste.html.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.